Jounce Therapeutics Inc. (JNCE) Fell -7.14% or -1.47 To Price $19.11 On Wednesday


Jounce Therapeutics Inc. (JNCE) fell -7.14% or -1.47 to $19.11. It is around 402007 shares traded, which is 111.51% compare to the average total volume 360528. The market cap of JNCE is $619.00 million. The year to date change is 53.58%. The 52 week price range is from $11.05 to $29.29. Price of JNCE have changed -8.66% during last week. It have changed -6.88% over last month, 43.02% over last 3 months, 16.60% over last 6 months and -8.90% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 23.81. It is 24.59% above current price. The 200-day Moving Averages for JNCE is 16.96. It is -11.25% below current price. The 52-week High is 29.29. It is 53.27% from the current price. The 52-week Low is 11.05. It is -42.18% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of JNCE is 10.02 on 2018-03-15. Short % to float is 12.69%. There are some statistics of JNCE. It is has market cap $619.00 million. The share outstanding is 32.39 million. The average volume is 360528. The revenue is 58.66M. The percent of top 15 Institution holding is 57.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -35.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -6.07%.


Tags:

Share this post